Sandoz Canada
Published on Sandoz Canada (https://www.sandoz.ca)

Home > Printer-friendly > Sandoz Canada launches Pr Amiodarone Syringe for the treatment of several heart rhythm disorders

Sandoz Canada launches Pr Amiodarone Syringe for the treatment of several heart rhythm disorders [1]

Publish Date: 
Aug 20, 2015

Boucherville, August 20, 2015 – Sandoz Canada Inc., a Novartis company, continues to innovate with the launch of Pr Amiodarone Syringe (PrAmiodarone Hydrochloride for Injection), in a more convenient format for this important medicine which is used in heart rhythm disorders, often used in emergency situations. 

Read More [2]


Source URL: https://www.sandoz.ca/en/node/20996

Links
[1] https://www.sandoz.ca/en/node/20996
[2] https://prod.sandoz.ca/sites/www.sandoz.ca/files/n_prod_1548590.pdf